These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 26810222)

  • 1. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
    Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
    J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
    Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
    Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
    Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
    Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
    Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
    PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability.
    Zhao Y; Shao Q; Zhu H; Xu H; Long W; Yu B; Zhou L; Xu H; Wu Y; Su Z
    Cancer Sci; 2018 Sep; 109(9):2677-2686. PubMed ID: 29959821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
    Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
    J Immunol; 2016 May; 196(9):3967. PubMed ID: 27183652
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
    Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
    J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy.
    Raber PL; Sierra RA; Thevenot PT; Shuzhong Z; Wyczechowska DD; Kumai T; Celis E; Rodriguez PC
    Oncotarget; 2016 Apr; 7(14):17565-78. PubMed ID: 27007050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.
    Beury DW; Carter KA; Nelson C; Sinha P; Hanson E; Nyandjo M; Fitzgerald PJ; Majeed A; Wali N; Ostrand-Rosenberg S
    J Immunol; 2016 Apr; 196(8):3470-8. PubMed ID: 26936880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism.
    Chen HM; Sun L; Pan PY; Wang LH; Chen SH
    Cancer Immunol Immunother; 2021 Dec; 70(12):3435-3449. PubMed ID: 33877384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
    Kotsakis A; Harasymczuk M; Schilling B; Georgoulias V; Argiris A; Whiteside TL
    J Immunol Methods; 2012 Jul; 381(1-2):14-22. PubMed ID: 22522114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.
    Tian J; Ma J; Ma K; Ma B; Tang X; Baidoo SE; Tong J; Yan J; Lu L; Xu H; Wang S
    PLoS One; 2012; 7(10):e46936. PubMed ID: 23077535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.
    Ornstein MC; Diaz-Montero CM; Rayman P; Elson P; Haywood S; Finke JH; Kim JS; Pavicic PG; Lamenza M; Devonshire S; Dann P; Schach K; Stephenson A; Campbell S; Emamekhoo H; Ernstoff MS; Hoimes CJ; Gilligan TD; Rini BI; Garcia JA; Grivas P
    Urol Oncol; 2018 Sep; 36(9):405-412. PubMed ID: 29606341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
    Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
    Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
    Tsukamoto H; Nishikata R; Senju S; Nishimura Y
    Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.